Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes

   
Zhdanov D.D.1 , Vasina D.A.2, Orlova E.V.3, Orlova V.S.4, Pokrovsky V.S.1, Pokrovskaya M.V.4, Aleksandrova S.S.4, Sokolov N.N.4

1. Institute of Biomedical Chemistry, Moscow, Russia; Peoples Friendship University of Russia, Ecological Faculty, Moscow, Russia
2. Peoples Friendship University of Russia, Ecological Faculty, Moscow, Russia
3. Institute of Theoretical and Experimental Biophysics, Puschino, Moscow region, Russia
4. Institute of Biomedical Chemistry, Moscow, Russia
Section: Experimental Study
DOI: 10.18097/PBMC20176301013      PubMed Id: 28251947
Year: 2017  Volume: 63  Issue: 1  Pages: 13-26
Alternative splicing of telomerase catalytic subunit hTERT pre-mRNA (human Telomerase Reverse Transcriptase) regulates telomerase activity. Increased expression of non-active splice variant hTERT results in inhibition of telomerase. Apoptotic endonuclease EndoG is known to participate in hTERT alternative splicing. Expression of EndoG can be induced in response to DNA damages. The aim of this study was to determine the ability of a DNA-damaging compound, cisplatin, to induce EndoG and its influence on alternative splicing of hTERT and telomerase activity in human CD4+ Т lymphocytes. Overexpression of EndoG in CD4+ T cells downregulated the expression of active full-length hTERT variant and upregulated its non-active spliced variant. Reduction of full-length hTERT caused downregulation of telomerase activity, shortening of telomeres length during cell divisions, converting cells to the replicative senescence state, activation of apoptosis and finally cell death. Few cells survived and underwent malignant transformation. Transformed cells have increased telomerase activity and proliferative potential compare to initial CD4+ T cells. These cells have phenotype of T lymphoblastic leukemic cells and are able to form tumors and cause death in experimental mice.
Download PDF:
Keywords: cisplatin, EndoG, telomerase, hTERT, alternative splicing, malignant transformation
Citation:

Zhdanov, D. D., Vasina, D. A., Orlova, E. V., Orlova, V. S., Pokrovsky, V. S., Pokrovskaya, M. V., Aleksandrova, S. S., Sokolov, N. N. (2017). Cisplatin-induced apoptotic endonuclease EndoG inhibits telomerase activity and causes malignant transformation of human CD4+ T lymphocytes. Biomeditsinskaya khimiya, 63(1), 13-26.
This paper is also available as the English translation: 10.1134/S199075081703012X
References  
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)